Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens. 2016

Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
Department of Pharmacy and Health Systems Sciences, Northeastern University.

Urinary tract infections (UTIs) are among the most commonly treated bacterial infections. Over the past decade, antimicrobial resistance has become an increasingly common factor in the management of outpatient UTIs. As treatment options for multidrug-resistant (MDR) uropathogens are limited, clinicians need to be aware of specific clinical and epidemiological risk factors for these infections. Based on available literature, the activity of fosfomycin and nitrofurantoin remain high for most cases of MDR Escherichia coli UTIs. Trimethoprim-sulfamethoxazole retains clinical efficacy, but resistance rates are increasing internationally. Beta-lactam agents have the highest rates of resistance and lowest rates of clinical success. Fluoroquinolones have high resistance rates among MDR uropathogens and are being strongly discouraged as first-line agents for UTIs. In addition to accounting for local resistance rates, consideration of patient risk factors for resistance and pharmacological principles will help guide optimal empiric treatment of outpatient UTIs.

UI MeSH Term Description Entries
D010045 Outpatients Persons who receive ambulatory care at an outpatient department or clinic without room and board being provided. Out-patients,Out patients,Out-patient,Outpatient
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D056689 Uropathogenic Escherichia coli Strains of Escherichia coli that preferentially grow and persist within the urinary tract. They exhibit certain virulence factors and infection pathways that cause URINARY TRACT INFECTIONS. Uropathogenic E. coli
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug

Related Publications

Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
November 2018, Turkish journal of urology,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
March 2014, Infectious disease clinics of North America,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
February 2010, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
July 1975, Current therapeutic research, clinical and experimental,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
April 2003, Pathologie-biologie,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
January 2006, Scandinavian journal of infectious diseases,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
July 1975, Current therapeutic research, clinical and experimental,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
July 1975, Current therapeutic research, clinical and experimental,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
November 2012, Antimicrobial agents and chemotherapy,
Emily Walker, and Alessandra Lyman, and Kalpana Gupta, and Monica V Mahoney, and Graham M Snyder, and Elizabeth B Hirsch
April 2016, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!